Cyclophosphamide and Total Body Irradiation in Treating Patients Who Are Undergoing an Autologous Peripheral Stem Cell Transplant For Chronic Lymphocytic Leukemia
Pivotal Study for High Dose Therapy and Autologous Stem Cell Transplantation in Early Stages of CLL
Sponsor: German CLL Study Group
Listed as NCT00275015, this PHASE2 trial focuses on Chronic Lymphocytic Leukemia and remains completed. Sponsored by German CLL Study Group, it has been updated 7 times since 1998, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
7 versions recorded-
Sep 2025 — Present [monthly]
Completed PHASE2
-
Sep 2024 — Sep 2025 [monthly]
Completed PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE2
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE2
-
Jun 2018 — Jan 2021 [monthly]
Completed PHASE2
▶ Show 2 earlier versions
-
Mar 2017 — Jun 2018 [monthly]
Completed PHASE2
-
Jan 2017 — Mar 2017 [monthly]
Completed PHASE2
First recorded
Jan 1998
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- German CLL Study Group
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Bad Saarow, Germany , Berlin, Germany , Bonn, Germany , Bremen, Germany , Dresden, Germany , Duisburg, Germany , Düsseldorf, Germany , Erlangen, Germany , Essen, Germany , Flensburg, Germany and 32 more locations